| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6042229 | Pediatric Neurology | 2014 | 5 Pages |
Abstract
Topical everolimus seems to be a favorable and safe option for patients with facial angiofibromas who do not require systemic treatment.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Patricia E. MD, Gaston MD, Peter MD, Uli PhD,